Health Condition 1: null- PRIMARY ADULT GLAUCOMA
Conditions
Interventions
Intervention1: Difluprednate 0.05%: Difluprednate is an ophthalmic topical corticosteroids .
Will be given as topical eye-drops 4 times/ day for 2 weeks preoperatively.
Control Intervention1: Carboxy
Sponsors
DIRECTOR
Eligibility
Inclusion criteria
Inclusion criteria: • Patients with primary adult glaucoma (POAG, PACG) • Age >40 years • Not controlled on maximum topical medical therapy (using 3 or more topical medications) for over 6 months • Patients willing to participate and able to comply with study procedures.
Exclusion criteria
Exclusion criteria: • One eyed patients • Age • Neovascular, uveitic, aphakic glaucoma and other causes of secondary glaucoma • History of previous glaucoma surgery or SLT • Cataract surgery within past 12 months • History of diabetes or any other systemic illness. • Any other chronic illness requiring anti-inflammatory therapy. • Pregnant or breast feeding women.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Primary Outcome - Intraocular pressure (IOP) Timepoint: 3 MONTHS, 6 MONTHS | — |
Secondary
| Measure | Time frame |
|---|---|
| â?¢Need for IOP lowering therapy â?¢Additional procedures â?? Needling â?¢Bleb Charactersitics â?¢Inflammtory aqueous markers Timepoint: 3 months , 6 months | — |
Countries
India
Contacts
Public ContactDR SHAHNAZ ANJUM
All India Institute Of Medical Sciences, New Delhi
Outcome results
None listed